Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

•Drug-resistant epilepsy (DRE) is considered a severe condition.•DRE is associated with important burden for patients and the healthcare system.•Cenobamate provides greater value than alternatives in DRE.•Multi-Criteria Decision Analysis helps to assess value contribution of cenobamate. Epilepsy is...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Epilepsy & behavior 2023-08, Vol.145, p.109350-109350, Article 109350
Hauptverfasser:	Falip, Mercè, López González, Francisco Javier, Martín-Herranz, Isabel, Merino-Bohórquez, Vicente, Montoya, Javier, Rey Gómez-Serranillos, Isabel, Rodriguez Uranga, Juan Jesús, Ruiz, Elías, Sancho-López, Aranzazu, Trillo Mata, Jose Luis, Antoni Vallès, Joan, Álvarez-Barón, Elena, Sabaniego, Joel, Subías-Labazuy, Silvia, Gil, Alicia
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiseizures medication Cenobamate Drug-resistant epilepsy Focal-Onset Seizures Multi-criteria decision analysis Spain
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!